Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Regeneron Pharmaceuticals, Inc.
FDA Inspection
•Regeneron Pharmaceuticals, Inc.•January 16, 2026

Regeneron Pharmaceuticals, Inc. – FDA Inspection, Jan 16, 2026

Record Details

This FDA Inspection record concerns Regeneron Pharmaceuticals, Inc., with an inspection on January 16, 2026, issued by the New York District Office, covering human drugs.

Company
Regeneron Pharmaceuticals, Inc.
Inspection Date
January 16, 2026
Product Type
Human Drugs
Office
New York District Office
People
  • Cassandra L. Abellard (Company Rep)
  • Harriet Touret (Issuing Officer)
  • Jangsong Bang (Issuing Officer)
  • Jiangsong Jiang (Issuing Officer)
View Company Profile

ID · 80f1263d-d05f-4449-b8b0-4d7778eba110

Inspection Facts

Inspection number
1291552
FDA center
Human Drugs
Outcome
Form 483 issued, view the record

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Regeneron Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.